Finland
· Delayed Price · Currency is EUR BONEH Statistics
Total Valuation
BBS-Bioactive Bone Substitutes Oyj has a market cap or net worth of EUR 1.76 million. The enterprise value is 6.49 million.
| Market Cap | 1.76M |
| Enterprise Value | 6.49M |
Important Dates
The next estimated earnings date is Friday, February 21, 2025.
| Earnings Date | Feb 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BBS-Bioactive Bone Substitutes Oyj has 25.30 million shares outstanding. The number of shares has increased by 107.69% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 25.30M |
| Shares Change (YoY) | +107.69% |
| Shares Change (QoQ) | +36.14% |
| Owned by Insiders (%) | 7.77% |
| Owned by Institutions (%) | 10.15% |
| Float | 19.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.37 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.83 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.39, with a Debt / Equity ratio of 1.47.
| Current Ratio | 0.39 |
| Quick Ratio | 0.39 |
| Debt / Equity | 1.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.68 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -148,192 |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.30% in the last 52 weeks. The beta is -0.51, so BBS-Bioactive Bone Substitutes Oyj's price volatility has been lower than the market average.
| Beta (5Y) | -0.51 |
| 52-Week Price Change | -87.30% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.36 |
| Relative Strength Index (RSI) | 13.65 |
| Average Volume (20 Days) | 179,330 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -15,619 |
| Operating Income | -3.38M |
| Pretax Income | -3.56M |
| Net Income | -3.56M |
| EBITDA | -3.17M |
| EBIT | -3.38M |
| Earnings Per Share (EPS) | -0.21 |
Balance Sheet
The company has 850,000 in cash and 5.58 million in debt, giving a net cash position of -4.73 million or -0.19 per share.
| Cash & Cash Equivalents | 850,000 |
| Total Debt | 5.58M |
| Net Cash | -4.73M |
| Net Cash Per Share | -0.19 |
| Equity (Book Value) | 3.79M |
| Book Value Per Share | 0.19 |
| Working Capital | -1.41M |
Cash Flow
| Operating Cash Flow | -3.07M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BBS-Bioactive Bone Substitutes Oyj does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -107.69% |
| Shareholder Yield | -107.69% |
| Earnings Yield | -304.33% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |